Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses

Acta Derm Venereol. 2022 Jul 7:102:adv00746. doi: 10.2340/actadv.v102.718.
No abstract available

MeSH terms

  • Bexarotene
  • Humans
  • Lymphoma, T-Cell, Cutaneous* / diagnosis
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Lymphoma, T-Cell, Cutaneous* / pathology
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology
  • T-Lymphocytes / pathology

Substances

  • Bexarotene